Criterios clínicos y de laboratorio para el uso de los inhibidores SGLT2 en la enfermedad renal crónica.
Chronic kidney disease (CKD) is characterized by a sustained reduction in glomerular filtration rate (GFR) and/or by markers of kidney damage. Sodium-glucose cotransporter type 2 inhibitors (SGLT2i) have shown renoprotective effects by inducing glycosuria through the inhibition of glucose reabsorpti...
Kaydedildi:
| Yazar: | |
|---|---|
| Diğer Yazarlar: | |
| Materyal Türü: | bachelorThesis |
| Dil: | spa |
| Baskı/Yayın Bilgisi: |
2025
|
| Konular: | |
| Online Erişim: | http://dspace.unach.edu.ec/handle/51000/15643 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
Etiketle İlk yorumlayan siz olun!